The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Changes in Albuminuria and Subsequent Risk of Incident Kidney Disease
Open accessAbstract
Background and objectives: Albuminuria is a robust predictor of CKD progression. However, little is known about the associations of changes in albuminuria with the risk of kidney events outside the settings of clinical trials. Design, setting, participants, & measurements: In a nationwide cohort of 56,946 United States veterans with an eGFR≥60 ml/min per 1.73 m 2 , we examined the associations of 1-year fold changes in albuminuria with subsequent incident CKD (>25% decrease in eGFR reaching <60 ml/min per 1.73 m 2 ) and rapid eGFR decline (eGFR slope <−5 ml/min per 1.73 m 2 per year) assessed using Cox models and logistic regression, respectively, with adjustment for confounders. Results: The mean age was 64 (SD, 10) years old; 97% were men, and 91% were diabetic. There was a nearly linear association between 1-year fold changes in albuminuria and incident CKD. The multivariable-adjusted hazard ratios (95% confidence intervals) of incident CKD associated with more than twofold decrease, 1.25- to twofold decrease, 1.25- to twofold increase, and more than twofold increase (versus <1.25-fold decrease to <1.25-fold increase) in albuminuria were 0.82 (95% confidence interval, 0.77 to 0.89), 0.93 (95% confidence interval, 0.86 to 1.00), 1.12 (95% confidence interval, 1.05 to 1.20), and 1.29 (95% confidence interval, 1.21 to 1.38), respectively. Qualitatively similar associations were present for rapid eGFR decline (adjusted odds ratios; 95% confidence intervals for corresponding albuminuria changes: adjusted odds ratio, 0.86; 95% confidence interval, 0.78 to 0.94; adjusted odds ratio, 0.98; 95% confidence interval, 0.89 to 1.07; adjusted odds ratio, 1.18; 95% confidence interval, 1.08 to 1.29; and adjusted odds ratio, 1.67; 95% confidence interval, 1.54 and 1.81, respectively). Conclusions: Relative changes in albuminuria over a 1-year interval were linearly associated with subsequent risk of kidney outcomes. Additional studies are warranted to elucidate the underlying mechanisms of the observed associations and test whether active interventions to lower elevated albuminuria can improve kidney outcomes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In type 1 diabetes, remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have reported inconsistent results (43,44).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [44]
In the citing paper
“In type 1 diabetes, remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have reported inconsistent results (43,44).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [44]
In the citing paper
“Remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have overall reported cardiovascular and kidney outcome benefits (9,45,46).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [46]
Citations
Cites
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Stevens, P. E., Levin, A., & for the Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group Members* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00007 · Cited by 3,607
(2013) · Kidney International Supplements · doi:10.1038/kisup.2012.73 · Cited by 3,206
Gerstein, H. C. (2001) · JAMA · doi:10.1001/jama.286.4.421 · Cited by 2,440
Hillege, H. L., Fidler, V., Diercks, G. F. H., van Gilst, W. H., de Zeeuw, D., van Veldhuisen, D. J., Gans, R. O. B., Janssen, W. M. T., Grobbee, D. E., & de Jong, P. E. (2002) · Circulation · doi:10.1161/01.cir.0000031732.78052.81 · Cited by 1,551
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Relation Between Kidney Function, Proteinuria, and Adverse Outcomes
Hemmelgarn, B. R. (2010) · JAMA · doi:10.1001/jama.2010.39 · Cited by 1,041
Coresh, J., Turin, T. C., Matsushita, K., Sang, Y., Ballew, S. H., Appel, L. J., Arima, H., Chadban, S. J., Cirillo, M., Djurdjev, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.6634 · Cited by 988 · cited 1×
“5 years after the first UACR measurement could be used for the 1-year fold change) (26).”
MethodSelf-citationAlbuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes
Ninomiya, T., Perkovic, V., de Galan, B. E., Zoungas, S., Pillai, A., Jardine, M., Patel, A., Cass, A., Neal, B., Poulter, N., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008121270 · Cited by 965
Cited by
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s011 · Cited by 460
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s011 · Cited by 398
11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s011 · Cited by 395
“In type 1 diabetes, remission of albuminuria may occur spontaneously, and cohort studies evaluating associations of change in albuminuria with clinical outcomes have reported inconsistent results (40,41).”
Result11. Chronic Kidney Disease and Risk Management: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s011 · Cited by 344
Coresh, J., Heerspink, H. J. L., Sang, Y., Matsushita, K., Arnlov, J., Astor, B. C., Black, C., Brunskill, N. J., Carrero, J.-J., Feldman, H. I., et al. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30313-9 · Cited by 338
Self-citation11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s011 · Cited by 318
10. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s010 · Cited by 302
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s011 · Cited by 289
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s011 · Cited by 275
11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s011 · Cited by 226
Randomized Controlled Trial of Exercise in CKD—The RENEXC Study
Hellberg, M., Höglund, P., Svensson, P., & Clyne, N. (2019) · Kidney International Reports · doi:10.1016/j.ekir.2019.04.001 · Cited by 99
“Thus, balance training emerges as an equally important form of exercise training for patients with CKD.”
BackgroundInfluentialKidney outcomes with finerenone: an analysis from the FIGARO-DKD study
Ruilope, L. M., Pitt, B., Anker, S. D., Rossing, P. R., Kovesdy, C. P., Pecoits‐Filho, R., Pérgola, P. E., Joseph, A., Lage, A. Z., Mentenich, N., et al. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfac157 · Cited by 89
Self-citationProteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis
Troost, J. P., Trachtman, H., Spino, C., Kaskel, F. J., Friedman, A. L., Moxey‐Mims, M., Fine, R. Ν., Gassman, J., Kopp, J. B., Walsh, L., et al. (2020) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2020.04.014 · Cited by 80
Diabetes mellitus type 2 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Sukhareva, O. Y., Galstyan, G. R., Tokmakova, A. Y., Nikonova, T. V., Surkova, E. V., Кононенко, И. В., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12507 · Cited by 68
Issa, N. S., Vaughan, L. E., Đenić, A., Kremers, W. K., Chakkera, H. A., Park, W. D., Matas, A. J., Taler, S. J., Stegall, M. D., Augustine, J. J., et al. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15259 · Cited by 56
Role of Albuminuria in Detecting Cardio-Renal Risk and Outcome in Diabetic Subjects
Pafundi, P. C., Garofalo, C., Galiero, R., Borrelli, S., Caturano, A., Rinaldi, L., Provenzano, M., Salvatore, T., Nicola, L. D., Minutolo, R., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11020290 · Cited by 43
“ADVANCE-ON [68] 2018 Perindopril/ Indapamide vs.”
BackgroundMicroalbuminuria and cardiorenal risk: old and new evidence in different populations
Márquez, D. F., Ruiz‐Hurtado, G., Segura, J., & Ruilope, L. M. (2019) · F1000Research · doi:10.12688/f1000research.17212.1 · Cited by 41
Fine Particulate Matter (PM2.5) and Chronic Kidney Disease
Zhang, Y., Liu, D., & Liu, Z. (2021) · Reviews of Environmental Contamination and Toxicology · doi:10.1007/398_2020_62 · Cited by 41
Kovesdy, C. P., Isaman, D. L., Petruski‐Ivleva, N., Fried, L. F., Blankenburg, M., Gay, A., Velentgas, P., & Folkerts, K. (2020) · Clinical Kidney Journal · doi:10.1093/ckj/sfaa200 · Cited by 28
“In contrast to changing eGFR values, previous research indicates that declining and increasing UACR over time results in better and worse health outcomes, respectively [20].”
ResultSelf-citationNakamura, T., & Kawaguchi, A. (2020) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.855 · Cited by 24
Diabetes mellitus type 1 in adults
Dedov, I. I., Shestakova, M. V., Mayorov, A. Y., Шамхалова, М. Ш., Nikonova, T. V., Sukhareva, O. Y., Пекарева, Е. В., Ibragimova, L. I., Mikhina, M. S., Galstyan, G. R., et al. (2020) · Diabetes Mellitus · doi:10.14341/dm12505 · Cited by 22
Change in albuminuria as a surrogate endpoint
Waijer, S. W., Gansevoort, R. T., & Heerspink, H. J. L. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000541 · Cited by 18
“Two large cohorts found a linear association between changes in albuminuria and risk of ESRD [15 & ] and incident CKD [16].”
BackgroundRecent advances of biosensors for hypertension and nephrology
Park, S. H., Zhang, Y., Rogers, J. A., & Gallon, L. G. (2019) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000517 · Cited by 17
“Albuminuria is a well-known risk factor for adverse kidney and cardiovascular outcomes as well as a potential surrogate marker for CKD progression [42].”
BackgroundDeletion of insulin receptor in the proximal tubule and fasting augment albumin excretion
Kumari, M., Sharma, R., Pandey, G., ECELBARGER, C. A., Mishra, P., & Tiwari, S. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28359 · Cited by 16
Zhong, M., Yang, Y., Zhang, Y.-Z., & Yan, S. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s303096 · Cited by 16
“A study on 56,946 United States veterans confirmed that changes in albuminuria were linearly associated with a risk of kidney outcomes over a 1-year interval.(15) Moreover, Viazzi et al also found that persistent albuminuria was associated with a greater risk of kidney events, and changes in albuminuria were associate…”
BackgroundCause-specific mortality in the general population with transient dipstick-proteinuria
Nagai, K., Yamagata, K., Iseki, K., Moriyama, T., Tsuruya, K., Fujimoto, S., Narita, I., Konta, T., Kondo, M., Kasahara, M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0223005 · Cited by 16
“Chronic kidney disease (CKD) is a risk factor for not only progression to end-stage kidney disease (ESKD), but also the development of cardiovascular disease (CVD) and all-cause mortality [1–7].”
BackgroundSelf-citationFast GFR decline and progression to CKD among primary care patients with preserved GFR
Koraishy, F. M., Hooks-Anderson, D. R., Salas, J., Rauchman, M. I., & Scherrer, J. F. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1805-1 · Cited by 15
Sodium-glucose cotransporter 2 inhibitors for diabetic kidney disease: a primer for deprescribing
Li, J., Fagbote, C. O., Zhuo, M., Hawley, C. E., & Paik, J. M. (2019) · Clinical Kidney Journal · doi:10.1093/ckj/sfz100 · Cited by 15
“However, diabetic patients with moderate to severe proteinuric CKD have a very high risk of progression to ESRD despite the current standard of care, which is a substantial unmet medical need.”
BackgroundKovesdy, C. P., Ebert, N., Vizcaya, D., Walsh, M., Kosiborod, M., Layton, J. B., ZIEMIECKI, R. M., Johannes, C. B., Pladevall, M., Gee, P. O., et al. (2025) · The Nephron journals/Nephron journals · doi:10.1159/000543923 · Cited by 14
Self-citationZhang, X., Bai, R., Zou, L., Zong, J., Yang, Q., & Wang, Y. (2021) · Journal of Diabetes Research · doi:10.1155/2021/8862573 · Cited by 14
“To minimize these confounding variables, two positive readings 3 months apart are needed to diagnose DN [22].”
BackgroundViazzi, F. C., Ceriello, A., Fioretto, P., Giorda, C. B., Guida, P., Russo, G. T., Greco, E., Cosmo, S. D., & Pontremoli, R. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001749 · Cited by 13
Qian, Q. (2018) · Nutrients · doi:10.3390/nu10060778 · Cited by 12
“AVP has been shown to induce glomerular hyperfiltration and proteinuria, both of which increase the risk of CKD [62] and mortality [63,64].”
BackgroundPark, S., Woo, J., Leem, S., Heo, N. H., Cho, N., Gil, H., Kim, J. H., & Lee, E. Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.882599 · Cited by 11
Tungsanga, S., Nantanawijit, R., Kiatamornrak, P., Kulvichit, W., Ngoensawat, U., Tachaboon, S., Dinhuzen, J., Chaisuriyong, W., Komolpis, K., Peerapornratana, S., et al. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-001412 · Cited by 10
Rizk, J. G., Hsiung, J., Arif, Y., Hashemi, L., Sumida, K., Kovesdy, C. P., Kalantar‐Zadeh, K., & Streja, E. (2023) · American Journal of Nephrology · doi:10.1159/000529414 · Cited by 8
Self-citationGrupper, A., Schwartz, D., Berliner, S. A., Shashar, M., Grupper, A., Baruch, R., Schwartz, I. F., Weinstein, T., Bassat, O. K., Rogowski, O., et al. (2018) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2018.08.003 · Cited by 8
Zheng, X., Yang, F., Chen, X., Yang, Y., Zhu, X., Chen, C., & Yang, J. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3432 · Cited by 6
Yokoyama, Y., Hanai, K., Mori, T., Yamamoto, Y., Yoshida, N., Murata, H., Shinozaki, T., & Babazono, T. (2023) · Clinical and Experimental Nephrology · doi:10.1007/s10157-023-02328-y · Cited by 5
Górriz, J. L., & Puchades, M. J. (2018) · Medicina de Familia SEMERGEN · doi:10.1016/j.semerg.2018.03.001 · Cited by 3
Zhang, J.-H., Hao, J.-C., Chang, D., Zhao, M., & Chen, M. (2026) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2026.109256 · Cited by 2
Epidemiologie und Pathogenese der diabetischen Nierenerkrankung
Ebert, T., & Halbritter, J. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0307-1 · Cited by 2
“Interessanterweise ist diese mit einem erniedrigten Risiko für die Entwicklung einer chronischen Niereninsuffizienz assoziiert [11].”
BackgroundGarzaro, J. R. R., Godoy, J. J. G., & Fuentes, Á. P. (2022) · Revista de la Facultad de Medicina · doi:10.37345/23045329.v1i33.88 · Cited by 2
Zoccali, C., & Bolignano, D. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734849477.793556999 · Cited by 2
Zhang, W., Dou, Y., Liu, J., Liu, T., Yan, W., Shen, Q., Xu, H. M., & Zhai, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-109833 · Cited by 1
“Proteinuria is an independent risk factor for CKD progression, 6–9 and reducing proteinuria is crucial for preventing CKD progression and protecting renal function.”
Shardlow, A. (2019) · Nottingham ePrints (University of Nottingham)
Tactics to prevent or slow progression of CKD in patients with diabetes
Ahmad (2021) · The Journal of Family Practice · doi:10.12788/jfp.0126
Kong, X., Yang, Z., Zhang, B., Yu, L., Zhu, H., Xing, X., Yang, W., & Chen, X. (2020) · doi:10.21203/rs.3.rs-24670/v1
Piscitelli, P. (2019) · The Journal of AMD · doi:10.36171/jamd19.22.4.02
Chronic Kidney Disease and Risk Management
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch18
Park, S., Woo, J., Leem, S., Heo, N. H., Cho, N.-J., Gil, H., Kim, J. H., & Lee, E. Y. (2022) · doi:10.3389/fcvm.2022.882599.s002
Metadata
- Authors
- Sumida, K., Molnar, M. Z., Potukuchi, P. K., George, K., Thomas, F., Lu, J. L., Yamagata, K., Kalantar-Zadeh, K., & Kovesdy, C. P.
- Affiliations
- University of Tsukuba (JP)
- Semmelweis University (HU)
- Division of Nephrology, Department of Medicine and
- University of Tennessee Health Science Center (US)
- Harold Simmons Center for Chronic Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California, Irvine, Orange, California; and
- Memphis VA Medical Center (US)
- Corresponding author
- Sumida, Keiichi
- Molnar, Miklos Z.
- Potukuchi, Praveen K.
- George, Koshy
- Kovesdy, Csaba P.
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2017-09-11
- Volume
- 12
- Issue
- 12
- Pages
- 1941-1949
- ISSN
- 1555-9041 (ISSN-L)
- 1555-905X
- PMC
- PMC5718265
- OpenAlex
- W2754503059
- Semantic Scholar
- d1856de616ff5926002002f9513294fe6cb26c8e
- Cited by
- 47
- References
- 48
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 1 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 7 · 2019: 12 · 2018: 7 · 2017: 1
- FWCI
- 6.61
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- U.S. Department of Veterans Affairs (SDR 02-237)
- Office of Research and Development
- Health Services Research and Development
- National Institutes of Health
- Centers for Medicare and Medicaid Services
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK096920)
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Health Sciences › Medicine › Nephrology › Renal Diseases and Glomerulopathies
- Keywords
- albuminuria, chronic kidney disease, estimated glomerular filtration rate decline, diabetic nephropathy, renal outcomes
- MeSH terms
- Aged, Albuminuria, Creatinine, Female, Glomerular Filtration Rate, Humans, Male, Middle Aged, Retrospective Studies, Risk Factors, United States, Incidence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.